Heartsine Technologies

HeartSine Technologies is a Belfast-based company that specializes in the design and manufacturing of automated external defibrillators (AEDs), enhancing public safety through innovative cardiac emergency solutions. HeartSine Technologies, founded in 1997 in Belfast, UK, specializes in the development of automated external defibrillators (AEDs). The company underwent a transition when Crescent divested its shareholding in Heartsine to management. The company has completed a total of 10 deals, with its latest funding round being a VENTURE DEBT round amounting to USD 2.

000 mn, which is also the total amount raised. The details of the current CEO and Founder are not provided. HeartSine Technologies, Ltd. specializes in the design and manufacturing of automated external defibrillators (AEDs) aimed at improving public safety during cardiac emergencies.

Their key products include the HeartSine SAM 350P, SAM 360P, and SAM 450P AEDs, all equipped with features like integrated real-time CPR feedback and high portability. HeartSine caters to a wide range of clients, including healthcare providers, educational institutions, and corporate entities, focusing primarily on markets in Europe, North America, and select regions in Asia. The company also offers training and compliance resources such as the HeartSine Gateway and Saver EVO software to support device management and training initiatives. In 2023, HeartSine recorded a revenue of USD 66,753,427.

90, with an EBITDA amounting to USD 8,633,771. 90. The company generates revenue through direct sales of its AED devices and training products, complemented by partnerships with distributors. Their financial model is driven by one-time AED purchases and ongoing sales of accessories like Pad-Paks, which combine pads and batteries, along with training solutions that enhance their overall product offering.

HeartSine Technologies is focused on developing new AED products designed to improve user experience and responsiveness to cardiac emergencies. The company is also planning to expand its presence into new geographic markets, particularly targeting regions in Asia and Europe by the end of 2025. The recent VENTURE DEBT funding will support these initiatives by providing the necessary capital for product development and market entry strategies.